Device type · QOF
Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
QOF
Microbiology
Device class
Class II
FDA decisions since 2015
39
510(k), De Novo and PMA
Adverse event reports
11
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents
- Product code
- QOF
- Device class
- Class II
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3981
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for QOF
Latest FDA decisions
The 8 newest of 39 since 2015.
K262938 · Decided Oct 30, 2026 · 70 days after receipt
Device type: Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents (QOF) · Laboratory Medicine & Pathology
K263333 · Decided Oct 22, 2026 · 30 days after receipt
Device type: Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents (QOF) · Laboratory Medicine & Pathology
K263120 · Decided Oct 2, 2026 · 28 days after receipt
Device type: Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents (QOF) · Laboratory Medicine & Pathology
36 more FDA decisions with a free account
Reports received
11
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
10
91% of reports
Injury reports
1
9.1% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 1 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 6 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 1 | 0 | 0 | 0 |
| Sep 24 | 4 | 1 | 0 | 0 |
| Oct 24 | 13 | 0 | 0 | 0 |
| Nov 24 | 4 | 0 | 0 | 0 |
| Dec 24 | 0 | 1 | 0 | 0 |
| Jan 25 | 0 | 1 | 0 | 0 |
| Feb 25 | 3 | 0 | 0 | 0 |
| Mar 25 | 1 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 1 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 3 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 1 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 2 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 1 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 7 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
1 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Manufacturing, Packaging or Shipping Problem6
- False Negative Result3
- False Positive Result2
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions11
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- BIOFIRE Respiratory Panel 2.1 (RP2.1) REF 423742 UDI code: 00815381020529 PCR-based multiplexed nucleic acid test, in vitro diagnosticOpen, Classified
Z-2936-2026 · Started Jun 24, 2026 · Posted by FDA Aug 12, 2026
Reason given: Due to increase in false negative results
Cause as FDA categorized it: Under Investigation by firm
- Biofire Spotfire Respiratory/Sore Throat Panel REF: 423485Open, Classified
Z-2081-2026 · Started Apr 1, 2026 · Posted by FDA May 6, 2026
Reason given: Respiratory/sore throat panel test may result in false negative results and control failures.
Cause as FDA categorized it: Under Investigation by firm
- BioFire Respiratory Panel 2.1, IVD, REF: 423742 (30 test kit)Open, Classified
Z-0602-2026 · Started Oct 22, 2025 · Posted by FDA Nov 26, 2025
Reason given: Due to unintended movement of pouch chemistry, nucleic acid test may result in elevated risk of false negative results and risk of control failures.
Cause as FDA categorized it: Under Investigation by firm
6 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.